A5035012183- Aortic Disease and Treatment Approaches
- Cardiac Valve Diseases and Treatments
- Aortic aneurysm repair treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Structural Anomalies and Repair
- Cardiac, Anesthesia and Surgical Outcomes
- Infectious Aortic and Vascular Conditions
- Congenital Heart Disease Studies
- Cardiac and Coronary Surgery Techniques
- Mechanical Circulatory Support Devices
- Cardiovascular Function and Risk Factors
- Hip and Femur Fractures
- Cardiac Imaging and Diagnostics
- Cardiovascular Issues in Pregnancy
- Cardiac Arrest and Resuscitation
- Aortic Thrombus and Embolism
- Connective tissue disorders research
- Renal and Vascular Pathologies
- Transplantation: Methods and Outcomes
- Trauma Management and Diagnosis
- Atrial Fibrillation Management and Outcomes
- Vasculitis and related conditions
- Cardiac pacing and defibrillation studies
- Renal Transplantation Outcomes and Treatments
- Emergency and Acute Care Studies
Cleveland Clinic
2016-2025
Valve (United States)
2015-2024
Cleveland Clinic Lerner College of Medicine
2012-2023
African Organisation for Research and Training in Cancer
2019-2023
Orthopedic Institute
2021-2023
RELX Group (United States)
2023
New York Proton Center
2023
Faculty of 1000 (United States)
2023
The Bronx Defenders
2023
Society of Thoracic Surgeons
2011-2022
Endovascular repair of thoracic aneurysm has demonstrated low risks mortality and spinal cord ischemia (SCI), but few large series have been published on endovascular thoracoabdominal repair, reports suffer from a lack accurate comparison with similar open surgical procedures.A consecutive cohort patients aneurysms treated electively (ER) or (SR) techniques between 2001 2006 were analyzed. The association technique SCI was evaluated univariable analysis. Adjustments for potential confounders...
Proteoglycan accumulation is a hallmark of medial degeneration in thoracic aortic aneurysm and dissection (TAAD). Here, we defined the proteoglycanome using mass spectrometry, based on findings, investigated large aggregating proteoglycans aggrecan versican human ascending TAAD mouse model severe Marfan syndrome. The comprises 20 including versican. Antibodies against these intensely stained lesions TAAD, contrasting with modest intralamellar staining controls. Aggrecan, but not versican,...
Background— Implantation of implantable cardioverter defibrillator for prevention sudden cardiac death is deferred 90 days after coronary revascularization, but mortality may be highest early procedures in patients with ventricular dysfunction. We determined risk postrevascularization left ejection fraction ≤35% and compared survival those discharged a wearable (WCD). Methods Results— Hospital survivors surgical (coronary artery bypass graft surgery) or percutaneous (percutaneous...